TY  - JOUR
AU  - Butt, Julia Anna
AU  - Jenab, Mazda
AU  - Pawlita, Michael
AU  - Overvad, Kim
AU  - Tjonneland, Anne
AU  - Olsen, Anja
AU  - Boutron-Ruault, Marie-Christine
AU  - Carbonnel, Franck
AU  - Mancini, Francesca Romana
AU  - Kaaks, Rudolf
AU  - Kühn, Tilman
AU  - Boeing, Heiner
AU  - Trichopoulou, Antonia
AU  - Karakatsani, Anna
AU  - Palli, Domenico
AU  - Pala, Valeria Maria
AU  - Tumino, Rosario
AU  - Sacerdote, Carlotta
AU  - Panico, Salvatore
AU  - Bueno-de-Mesquita, Bas
AU  - van Gils, Carla H
AU  - Vermeulen, Roel C H
AU  - Weiderpass, Elisabete
AU  - Quirós, José Ramón
AU  - Duell, Eric Jeffrey
AU  - Sánchez, Maria-Jose
AU  - Dorronsoro, Miren
AU  - Huerta, José María
AU  - Ardanaz, Eva
AU  - Van Guelpen, Bethany
AU  - Harlid, Sophia
AU  - Perez-Cornago, Aurora
AU  - Gunter, Marc J
AU  - Murphy, Neil
AU  - Freisling, Heinz
AU  - Aune, Dagfinn
AU  - Waterboer, Tim
AU  - Hughes, David J
TI  - Antibody Responses to Fusobacterium nucleatum Proteins in Prediagnostic Blood Samples are not Associated with Risk of Developing Colorectal Cancer.
JO  - Cancer epidemiology, biomarkers & prevention
VL  - 28
IS  - 9
SN  - 1538-7755
CY  - Philadelphia, Pa.
PB  - AACR
M1  - DKFZ-2019-02194
SP  - 1552 - 1555
PY  - 2019
N1  - #EA:F022#
AB  - There is a lack of prospective data on the potential association of Fusobacterium nucleatum (F. nucleatum) and colorectal cancer risk. In this study, we assessed whether antibody responses to F. nucleatum are associated with colorectal cancer risk in prediagnostic serum samples in the European Prospective Investigation into Nutrition and Cancer (EPIC) cohort.We applied a multiplex serology assay to simultaneously measure antibody responses to 11 F. nucleatum antigens in prediagnostic serum samples from 485 colorectal cancer cases and 485 matched controls. Conditional logistic regression models were used to estimate odds ratios (ORs) and 95
LB  - PUB:(DE-HGF)16
C6  - pmid:31481495
DO  - DOI:10.1158/1055-9965.EPI-19-0313
UR  - https://inrepo02.dkfz.de/record/144762
ER  -